IMMIX BIOPHARMA INC (IMMX) Stock Earnings & Estimates
NASDAQ:IMMX - US45258H1068 - Common Stock
2.22 USD
-0.07 (-3.06%)
2.28 USD
+0.06 (+2.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 132.35% | N/A 37.97% | N/A 32.11% | N/A 18.06% | |||||||
| EBITDA YoY % growth | -840K | -450K 46.43% | -1.35M -200.00% | -8.22M -508.89% | -16.136M -96.30% | -22.559M -39.81% | N/A 6.40% | N/A -32.32% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -840K | -450K 46.43% | -1.35M -200.00% | -8.22M -508.89% | -16.141M -96.36% | -22.675M -40.48% | N/A 2.66% | N/A -27.51% | N/A 189.89% | N/A 244.13% | N/A 84.22% | N/A 44.06% | N/A 23.92% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -0.88 -76.55% | N/A 14.46% | N/A 15.99% | N/A -18.55% | N/A 212.93% | N/A 228.92% | N/A 38.83% | N/A 37.99% | N/A 18.55% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 32.00% | -0.15 4.38% | -0.14 4.80% | -0.15 30.45% | -0.17 -6.25% | -0.19 -26.67% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.346M 27.71% | -5.627M -12.84% | -5.9M -25.98% | -6.534M 2.73% | -7.576M -41.71% | -8.177M -45.31% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.22 -46.67% | -0.16 | -0.06 | -34.80% |
| Q1 2025 Q2Q % growth | -0.15 36.06% | -0.23 | 0.08 | 36.06% |
| Q4 2024 Q2Q % growth | -0.16 30.43% | -0.26 | 0.10 | 37.25% |
| Q3 2024 Q2Q % growth | -0.24 -4.35% | -0.16 | -0.08 | -47.06% |
| Q2 2024 Q2Q % growth | -0.15 37.50% | -0.21 | 0.06 | 29.97% |
| Q1 2024 Q2Q % growth | -30.33% | -0.23 | % | |
| Q4 2023 Q2Q % growth | -0.23 14.81% | -0.23 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.23 | -0.23 | 0.00 | 1.96% |
| Q2 2023 Q2Q % growth | -0.24 | -0.17 | -0.07 | -38.41% |
| Q1 2023 Q2Q % growth | -0.18 | -0.14 | -0.04 | -26.05% |
| Q4 2022 Q2Q % growth | -0.27 | -0.22 | -0.05 | -20.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 27.27% | -4.2% | 23.93% |
| Revenue | N/A | N/A | N/A | N/A |